Schering-Plough to pay $435 million in off-label marketing case

RSS

From this AP article:


    Schering-Plough Corp. on Tuesday agreed to pay $435 million and plead guilty to conspiracy to settle a federal investigation into marketing of its drugs for unapproved uses and overcharging Medicaid for certain drugs.


    Kenilworth, N.J.-based Schering-Plough said it will pay $255 million to resolve civil aspects of the previously disclosed investigation. A subsidiary, Schering Sales Corp., will pay a criminal fine of $180 million and plead guilty to one count of conspiracy to make false statements to the government. The agreement is subject to court approval.



Among the changes implemented since this off-label marketing occurrence, the company has prohibited its sales reps from becoming involved in the CME granting process.

Please or Register to post comments.

Blog Archive

Sponsored Introduction Continue on to (or wait seconds) ×